Patients thank blood donors for life-saving plasma
A patient from Telford who needed a lifesaving treatment developed from blood plasma has thanked donors. Over the past three ...
pharmaphorum4d
Sanofi’s rare disease drug Cablivi approved in the EU
The European Commission has approved Sanofi’s Cablivi, the first treatment for patients with the rare blood-clotting disorder, acquired thrombotic thrombocytopenic purpura (aTTP), which is also ...
Shropshire Star3d
Lifesaving medicine from Shropshire donors making a huge difference to patients across the country
NHS patients around the country are receiving a lifesaving medicine made from the plasma of blood donors in Shropshire.
Labiotech.eu5d
Rare Disease Day: seven drugs awaiting approval in 2025
As we observe Rare Disease Day today, let us take a look at seven drugs poised to be approved to address rare diseases in ...
pharmaphorum3d
Takeda CEO succession confirmed as Weber plans retirement
Kim will oversee the rollout of Eohilia and other recent launches like colorectal cancer treatment Fruzaqla (fruquintinib) and Adzynma for congenital thrombotic thrombocytopenic purpura (cTTP ...
casereports.bmj11d
Immune-mediated TTP secondary to checkpoint inhibitor use in a patient with stage IV melanoma
A growing body of literature suggests the possibility of thrombotic thrombocytopenic purpura (TTP) secondary to immunotherapy use, and thus a high index of suspicion is needed in these patients for ...